« Back to Record
Citation APA

de Azambuja, E., Lemort, M., Rossari, J., Moulin, C., Buttice, A., D'Hondt, V., Lebrun, F., Lalami, Y., Cardoso, F., Sotiriou, C., Gil, T., Devriendt, D., Marinus, W., Paesmans, M., Piccart-Gebhart, M., & Awada, A. (2011). Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172). J Clin Oncol: ASCO Annual Meeting Proceedings. Vol. 29, 15 Suppl, Part I (p. 62) Abstract session presented at ASCO Annual meeting 2011(June 2011: Chicago, IL, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/159043

de Azambuja, E., Lemort, M., Rossari, J., Moulin, C., Buttice, A., D'Hondt, V., Lebrun, F., Lalami, Y., Cardoso, F., Sotiriou, C., Gil, T., Devriendt, D., Marinus, W., Paesmans, M., Piccart-Gebhart, M., & Awada, A. (2011). Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172). J Clin Oncol: ASCO Annual Meeting Proceedings. Vol. 29, 15 Suppl, Part I (p. 62) Abstract session presented at ASCO Annual meeting 2011(June 2011: Chicago, IL, USA).